Control Medical Technology innovates, develops, and commercializes medical devices for thrombus removal, biospy, tissue resection, and drainage for use in cardiovascular, orthopedics, oncology, and general care. The company owns the license to 6 combined issued and pending patents. Reimbursement is established in the company’s core markets. Control has distribution agreements with partners in the United States, European Union, and Japan. Control Medical's management team formerly led Pinyons Medical Technology, Park City, Utah. Within 28-months of Pinyons funding, Pinyons’ team innovated a new angiographic injector, manufactured the device with over 20-molds, 510k cleared the platform, published in-vivo data, won a 2008 Medical Device Design Award, and sold the company Covidien.
